Discover 157 paid clinical trials in Eugene, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 157
Active & Responsive
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
for
Breast Cancer
Location: Eugene OR, Portland OR, Redding CA, Seattle WA,
Sponsor: Agendia
Sex: All
Age: 18+
Code: NCT03053193
Recruiting
Active & Responsive
Leveraging Parents and Peers to Increase Recovery Capital in Emerging Adults
for
Polysubstance Drug Use (Indiscriminate Drug Use)
Location: Eugene OR
Sponsor: Chestnut Health Systems
Sex: All
Age: 18+
Code: NCT06414993
Recruiting
Active & Responsive
A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)
for
Neoplasms
Location: Eugene OR, Puyallup WA, Seattle WA, Los Angeles CA,
Sponsor: Tesaro, Inc.
Sex: All
Age: 18+
Code: NCT02817633
Phase1, Recruiting
New
Post-Market Clinical Study of Functional Motion Outcomes in Subjects Treated With the Minuteman Device
for
Degenerative Conditions of the Lumbar Spine,
Location: Eugene OR, Edina MN, Indianapolis IN, Charleston WV,
Sponsor: Spinal Simplicity LLC
Sex: All
Age: 18+
Code: NCT06355791
Recruiting
New
Evaluation of Aim to Play, a User-Friendly Digital Application for Teacher Skills Training and Physical Education Activities for 3-5 Grade Students
for
Teacher Self-efficacy for Teaching PE, Teacher PE Instruction,
Location: Eugene OR, Springfield OR
Sponsor: Saavsus, Inc.
Sex: All
Age: 7+
Code: NCT07203313
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease
for
Breast Cancer
Location: Eugene OR, Springfield OR, Albany OR, Portland OR,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT06760637
Phase3, Recruiting
A Study to Assess Adverse Events of Intravenously (IV) Infused ABBV-383 in Adult Participants With Relapsed or Refractory Multiple Myeloma
A Study to Evaluate the Effect of Venetoclax on Participants Receiving a Covalent Bruton's Tyrosine Kinase Inhibitor (cBTKi) for First-line Chronic Lymphocytic Leukemia (1L CLL) to Achieve Deep Durable Remissions to Allow Off-treatment Period.
for
Chronic Lymphocytic Leukemia
Location: Eugene OR, Medford OR, Aurora CO, Grand Island NE,
Sponsor: Genentech, Inc.
Sex: All
Age: 18+
Code: NCT06524375
Phase2, Recruiting
OssiMend BA in Posterolateral Instrumented Lumbar Fusion